Wee Joo Chng
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments 160
- Acute Myeloid Leukemia Research 39
- Oncology top 0.5%
- Peptidase Inhibition and Analysis 36
- Cancer Research top 1%
- Molecular Biology top 0.5%
- Protein Degradation and Inhibitors 93
- Ubiquitin and proteasome pathways 37
- Histone Deacetylase Inhibitors Research 28
- Genetics top 0.5%
-
- Lymphoma Diagnosis and Treatment 40
-
- Immune Cell Function and Interaction 30
- Co-authors
- Jianbiao ZhouRafaël FonsecaSiok‐Bian NgChonglei BiPhaik Ju TeohTae‐Hoon ChungP. Leif BergsagelSanjay De Mel
- Cited by
- HematologyOncologyCancer Research
- Partner nations
- SingaporeUnited StatesChina
In The Last Decade
Wee Joo Chng
359 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Hematology 4.0k
- Oncology 3.6k
- Cancer Research 1.6k
- Molecular Biology 7.2k
- Genetics 1.0k
Countries citing papers authored by Wee Joo Chng
This map shows the geographic impact of Wee Joo Chng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wee Joo Chng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wee Joo Chng more than expected).
Fields of papers citing papers by Wee Joo Chng
This network shows the impact of papers produced by Wee Joo Chng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wee Joo Chng. The network helps show where Wee Joo Chng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wee Joo Chng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2021 | 37 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 0 | |
| 14 | 2017 | 11 | |
| 15 | 2017 | 12 | |
| 16 | 2016 | 30 | |
| 17 | 2015 | 41 | |
| 18 | 2014 | 28 | |
| 19 | 2013 | 159 | |
| 20 | 2007 | 195 |
About Wee Joo Chng
Wee Joo Chng is a scholar working on Hematology, Genetics and Oncology, having authored 386 papers that have together received 11.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (160 papers), Protein Degradation and Inhibitors (93 papers), Lymphoma Diagnosis and Treatment (40 papers), Acute Myeloid Leukemia Research (39 papers), Ubiquitin and proteasome pathways (37 papers), Peptidase Inhibition and Analysis (36 papers), Immune Cell Function and Interaction (30 papers) and Histone Deacetylase Inhibitors Research (28 papers). The work is most often cited by research in Hematology (4.0k citations), Oncology (3.6k citations) and Cancer Research (1.6k citations). Wee Joo Chng has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Jianbiao Zhou, Rafaël Fonseca, Siok‐Bian Ng, Chonglei Bi, Phaik Ju Teoh, Tae‐Hoon Chung, P. Leif Bergsagel, Sanjay De Mel, Angela Dispenzieri and Qiang Yu. Their work appears in journals such as Blood, Leukemia, Oncotarget, Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.